Its important to remember that a doctor will decide the right dose and how often to give it
According to our data, this could be explained by higher rates of discontinuation and lower maintenance dosages used in clinical practice, compared to randomized clinical trial settings. Gasoyan was the lead author of the study published on Tuesday in the Obesity Journal
Significance of the research This study clarifies the controversy regarding the effect of GLP-1 receptor agonists on body composition as a weight-management medication, and showcases how a genetic approach can enhance our understanding of how medications work
That's because Mounjaro is a dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, which may make it more effective at controlling blood sugar levels and supporting weight loss
Pharmacists may do this for people who cannot take the FDA-approved version of a drug
The major active ingredient in Zepbound is tirzepatide, which mimics a hormone that decreases the desire for food